Pemphigus in Israel--an epidemiologic analysis of cases in search of risk factors.
BACKGROUND
Despite the high incidence of pemphigus in the Jewish population, data on the epidemiology and etiology of the disease in Israel are sparse.


OBJECTIVE
This study was conducted to identify clinical and epidemiologic features of pemphigus patients in Israel, while searching for risk factors that induce or exacerbate the disease.


METHODS
Demographic and clinical information was recorded from the charts of 55 pemphigus patients treated over a 5 year period. A sample of 22 patients was compared to 22 age and gender-matched controls by means of a questionnaire querying details on lifestyle, including occupation, diet, sun exposure, and smoking.


RESULTS
The findings show that the typical Israeli pemphigus patient is middle-aged, married, and of East European or Middle Eastern origin. The most common diagnosed clinical variant was pemphigus vulgaris, followed by pemphigus erythematosus. Some 70% of patients were treated with two or more immunosuppressive drugs and 62% entered long-lasting remission. Twenty-three percent of patients were exposed through their work to chemical substances, mainly pesticides, at the beginning of the disease and 18% of patients were continually exposed to ultraviolet radiation 5 years prior to onset of the disease.


CONCLUSIONS
There is a possible correlation between occupational exposure to pesticides and UV radiation, and pemphigus induction.
Wohl
Yonit
Y
Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Brenner
Sarah
S
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D005260:Female; D015386:Hazardous Substances / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007557:Israel / Q000453:epidemiology; D008019:Life Style; D008297:Male; D017533:Marital Status; D008875:Middle Aged; D016273:Occupational Exposure / Q000009:adverse effects; D010392:Pemphigus / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology*; D011159:Population Surveillance; D015995:Prevalence; D012074:Remission Induction; D012111:Residence Characteristics; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D011795:Surveys and Questionnaires; D014466:Ultraviolet Rays / Q000009:adverse effects
D015386:Hazardous Substances; D007166:Immunosuppressive Agents